Low levels of TS have been observed in oxaliplatin-resistant gastric cancer cell lines (Chen et al, 2007), providing a plausible potential explanation of why a meaningful number of patients with low ERCC1 and high TS levels had the longest survival in the present study (Figure 2). The gene discussed is TYMS; the disease is gastric cancer.